Shiff Susan Ph.D. 4
4 · Cara Therapeutics, Inc. · Filed Jun 30, 2020
Insider Transaction Report
Form 4
Shiff Susan Ph.D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-26+38,000→ 38,000 totalExercise: $17.03Exp: 2030-06-26→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on September 26, 2020 such that the option will be fully vested and exercisable on June 26, 2023, subject to the Reporting Person's continued service to the Issuer on each such date.